Gerald B. Fogarty
Experienced in Erythema Multiforme

Gerald B. Fogarty

160 Oxford St, 
Darlinghurst, NSW, AU 
Experienced in Erythema Multiforme
160 Oxford St, 
Darlinghurst, NSW, AU 
OverviewLocationsClinical Research

Overview

Gerald Fogarty practices in Darlinghurst, Australia. Mr. Fogarty is rated as an Experienced expert by MediFind in the treatment of Erythema Multiforme. His top areas of expertise are Melanoma, Neuroendocrine Tumor, Melasma, and Merkel Cell Carcinoma.

His clinical research consists of co-authoring 60 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Erythema Multiforme.

Gender
Male

Locations

160 Oxford St, Darlinghurst, NSW 2010, Australia
Other Locations
St Vincents Hospital, Darlinghurst, NSW, Australia
25 Rocklands Road, Crows Nest, NSW 2060, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An Open-label, Single-arm, Phase I/II, Multicentre Study to Evaluate the Safety and Efficacy of the Combination of Dabrafenib, Trametinib and Palliative Radiotherapy in Patients with Unresectable (stage IIIc) and Metastatic (stage IV) BRAF V600E/K Mutation-positive Cutaneous Melanoma
An Open-label, Single-arm, Phase I/II, Multicentre Study to Evaluate the Safety and Efficacy of the Combination of Dabrafenib, Trametinib and Palliative Radiotherapy in Patients with Unresectable (stage IIIc) and Metastatic (stage IV) BRAF V600E/K Mutation-positive Cutaneous Melanoma
Enrollment Status: Completed
Publish Date: November 27, 2024
Intervention Type: Radiation, Drug
Study Drug: Dabrafenib and Trametinib (Combination)
Study Phase: Phase 1/Phase 2
A Randomised Controlled Multicentre Trial of Imiquimod Versus Radiotherapy for Lentigo Maligna (LM) When Staged Surgical Excision With 5mm Margins is Not Possible, is Refused, or Fails
A Randomised Controlled Multicentre Trial of Imiquimod Versus Radiotherapy for Lentigo Maligna (LM) When Staged Surgical Excision With 5mm Margins is Not Possible, is Refused, or Fails
Enrollment Status: Completed
Publish Date: June 20, 2024
Intervention Type: Drug, Radiation
Study Drug: Imiquimod
Study Phase: Phase 3
Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma - A Randomised Phase III Trial
Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma - A Randomised Phase III Trial
Enrollment Status: Unknown
Publish Date: January 07, 2021
Intervention Type: Radiation
Study Phase: Not Applicable
View 2 Less Clinical Trials

60 Total Publications

Narrative review of the impact on physicians of administering euthanasia or physician-assisted suicide and its association with moral distress.
Narrative review of the impact on physicians of administering euthanasia or physician-assisted suicide and its association with moral distress.
Journal: Palliative & supportive care
Published: June 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Fogarty's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile